Skip to main content
. 2017 Oct 17;9(10):1133. doi: 10.3390/nu9101133

Table 1.

Macular carotenoid concentration of the commercially available supplements analysed.

Supplement Name Type Batch Number Expiry Time to Expiry at Time of Testing (Months) Macular Carotenoid (mg/Capsule)
Declared Measured x¯ ± SD
MacuSafe 1 12603 June 2019 28 L→10 1.92 ± 0.09
Z→2 1.14 ± 0.02
MZ→12 9.66 ± 0.28
Eye Vitality Plus 1 13577 August 2019 31 L→15 4.35 ± 0.42
Z→2 1.46 ± 0.06
MZ→10 8.32 ± 0.59
Vision Alive 1 424951 June 2018 14 L→10 7.38 ± 0.27
Z→nc 1.24 ± 0.02
MZ→nc 1.58 ± 0.04
MacuSave 2 3001777 August 2019 35 L→10 11.01 ± 0.13
Z→2 3.23 ± 0.02
MZ→10 9.67 ± 0.11
Doctors Best 2 16052523A December 2019 32 L→20 21.33 ± 1.39
Z→2 2.35 ± 0.30
MZ→1 3.19 ± 0.19
Lutigold Extra 2 462536-02 August 2019 27 L→20 19.65 ± 1.02
Z→nq 2.14 ± 0.15
MZ→nq 3.05 ± 0.11
MacuHealth 2 C1600284 September 2019 25 L→10 11.32 ± 0.06
Z→2 2.72 ± 0.18
MZ→10 12.60 ± 0.26
MacuShield 2 120480 March 2017 4 L→10 12.24 ± 0.41
Z→2 11.98 ± 0.43
MZ→10 13.21 ± 0.48
Maxivision * 3 33690818 None No expiry date on product L→10 10.82
Z→2 3.68
MZ→10 11.19

1 = powder filled capsule 2 = oil filled soft gel gelatin capsule 3 = powder filled beadlet formulation. nc = not claimed on product label n/a = not applicable nq = not quantified on label * Supplement extraction method 2: Beadlet analysis (n = 1). The oil filled soft gel capsules analysed included: MacuSave (Zeon healthcare Ltd., Oxfordshire, UK), Doctor’s Best (Doctor’s Best Inc., San Clemente, CA, USA), Lutigold Extra (Puritans Pride Inc., Oakdale, NY, USA), MacuHealth LMZ3 (MacuHealth, Birmingham, MI, USA), and MacuShield (Alliance Pharma PLC, Wiltshire, UK). The powder filled capsules analysed included: MacuSafe (OcuSci, Del Mar, CA, USA), Eye Vitality Plus (Green Valley Hyperion LLC, Lexington, VA, USA) and Vision Alive (Holistic Labs Ltd., Hollywood, FL, USA). The beadlet formulation analysed was: MaxiVision (MedOp Health Inc., Oldsmar, FL, USA). One capsule of MaxiVision was analysed; the rest of the supplements were analysed in triplicate.